This category is a range of camping lights, our products are high quality, easy to carry, available in a variety of camping string lights,led camping light,camping lights for tent,solar camping light,rechargeable camping light Ningbo Autrends International Trade Co., Ltd. , https://www.autrendstents.com
Digital development
For 30 years, the growth rate of China's pharmaceutical industry has been higher than the gross domestic product (GDP). From 1978 to 2007, the average annual output value of the pharmaceutical industry increased by 16.8%, becoming one of the fastest growing industries in the national economy. Not only that, the chemical and pharmaceutical industry, which accounts for the largest proportion of China's pharmaceutical industry, has also achieved considerable development. In 2007, China's chemical and pharmaceutical industry realized industrial output value of 307.4 billion yuan, an average increase of 15% from 1978 to 2007, and realized a total profit of 29.4 billion yuan, an average increase of 11.9%. In 2007, the annual national chemical raw material output reached 1.1 million tons. The proportion of exports exceeds 40%, accounting for 1/4 of the global trade in bulk drugs.
Product reading: Experienced a transition from a planned economy to a market economy. It has undergone a process of rigid procurement and marketing from a country that lacks competition, to the beginning of an unordered competition in the market, and gradually to a normative and orderly development process in competition. The overall level of China's pharmaceutical industry has greatly increased, and it has become one of the fastest growing industries in the national economy. It can be said that after 30 years of development, China has achieved a transition to a big pharmaceutical country.
Seen across the numbers
In 2007, the annual output of tablets, capsules, granules, freeze-dried powder injections, powder injections, infusions and injections, seven types of chemical drug preparations, reached 456 billion tablets, 82.1 billion tablets, 10.6 billion packets (bags) , 1 billion bottles, 9.2 billion bottles, 7.2 billion bottles (bags) and 33.1 billion. At present, China can produce more than 1,500 kinds of APIs. China's formulation products can produce more than 50 dosage forms and 3500 varieties. China can produce 41 kinds of vaccines that prevent the infection of 26 kinds of viruses and bacteria. The annual output exceeds 1 billion dose units.
Reading: After 30 years of unremitting efforts, the situation of lack of medical care in our country has changed. With the growing scale of China's pharmaceutical economy, not only the commonly used drugs and necessary drugs for clinical use, but also the drugs needed for common diseases in some developing countries (communicable diseases, endemic diseases, etc.) can basically be produced and supplied. Variety production ranks first in the world. Artemisinin products produced in China are widely used in the world and have made important contributions to the prevention and treatment of malaria; the output of antibiotics, hormones, and amino acids in China also holds a considerable share in the international pharmaceutical market; China's domestic vaccines While meeting the disease prevention needs of urban and rural residents in China, it can also be provided to the World Health Organization for the prevention of diseases in other countries. Our country has already become a major global pharmaceutical producer.
Look at the benefits in numbers
In 1987, China's pharmaceutical business sales were 19.748 billion yuan, in 2006 it reached 335.9 billion yuan, and the latter was nearly 20 times that of the former; in 1987, China's pharmaceutical business profit was 979 million yuan, in 2006 it reached 2.348 billion yuan, Some time. Before China's accession to the WTO in 2001, there were roughly 17,000 pharmaceutical and commercial enterprises, and there were only 10 or more sales exceeding 1 billion yuan, and only 3 to 6 companies exceeding 5 billion yuan. In 2007, there were 3 pharmaceutical commercial enterprises with sales of over 10 billion yuan in China, 9 companies with more than 5 billion yuan, and 17 companies with more than 3 billion yuan.
Reading: Many, small, scattered, chaotic, outdated equipment, backward management, there is a serious non-standard business, is the portrayal of China's pharmaceutical business. After 30 years of continuous rectification and regulation, China's pharmaceutical business has undergone significant changes, gradually moving into the fast lane of healthy development during the standardization process. While the commercial value has greatly increased, the trend of large-scale marketization is taking shape.
Look at the change in numbers
As of July 2007, a drug supply network has been established in 507,000 administrative villages in the country's 601,000 administrative villages, with a drug supply network coverage rate of 84.39%. The coverage of the national drug supervision network reached 85.18%, with 86,400 drug supervision coordinators and 470,000 information workers.
Reading: In the past 30 years, China's rural drug market has grown from scratch, from chaos to cure. In recent years, the country has vigorously promoted the construction of the rural drug supervision network and supply network, rationalized the channels for rural drug supply, not only ensured better protection of the use of drugs by rural people, but also promoted timely, convenient and inexpensive use of drugs by rural people. Reduce the burden on farmers for drugs. See innovation in numbers
From 1985 to 1996, China had approved 1,218 new western medicines, of which only 54 were innovative drugs, and more than 60% were four types of drugs that were modified; between 1998 and 2007, a total of 78 new drugs were approved in China; Since 2007, China has accepted 553 new drug registration applications, 825 generic drug applications, the number of new drug registration applications has increased, and the number of generic drug registration applications has dropped significantly. At present, there are 200,000 scientific researchers in China engaged in biotechnology research, and a total of 475 ordinary higher education institutions that set up pharmaceutical specialty in China.
Reading: As the new drug R&D system continues to improve, dramatic changes have taken place in China's drug development field. Research and development of new drugs has evolved from initial imitation to independent innovation. China's innovative drug research and development atmosphere is getting stronger, and intellectual property protection, infrastructure construction, human resources, etc. all have considerable advantages, and a new era of trending and scientific drug development is coming.
Digital quality
In 1996, the China National Institute for the Control of Pharmaceutical and Biological Products organized drug inspections at various levels throughout the country to carry out a sampling inspection of drug quality, with a total pass rate of 83.53%. In 2007, the state conducted 13595 batches of appraisal sampling for proprietary Chinese medicines, chemical drugs, and biological products, and the overall qualification rate was 98.0%. Among them, the pass rate of chemical drugs reached 98.0%, the pass rate of antibiotics was 98.1%, and the pass rate of Chinese patent drugs was 97.6%. The sampling rate of flu vaccines is 100% for two consecutive years.
Reading: The course of 30 years of reform and opening up is the process of extensive and regular supervision of pharmaceuticals from weak to strong. Through the gradual establishment and improvement of the drug regulatory system, the regulatory level of the entire drug process has been greatly improved, which has effectively guaranteed the quality and safety of pharmaceutical products in China.
Security in numbers
At present, 31 provinces (autonomous regions, municipalities directly under the central government) have established provincial-level monitoring agencies for adverse drug reactions, and more than 200 provincial-level or lower-level adverse drug reaction monitoring centers or monitoring stations have been developed. In 2007, the number of reported cases of adverse drug reactions in the country was more than 400 per million population. The number of reports of adverse drug reactions was close to the monitoring rate of developed countries.
Product reading: At present, the national adverse drug reaction monitoring information network covers the whole country, and electronic reports and online real-time reports have been implemented. The adverse drug reaction monitoring system has achieved unprecedented results in terms of laws and regulations, institution building, and informatization, etc., monitoring of adverse drug reactions and The early-warning capability has been greatly improved, and it has become an important means for ensuring the safety of drug use. It is an important basis and guarantee for drug safety supervision in China.
Looking into the future
There are more than 15,000 kinds of national drug standards in China, and the overall level of the latest 2005 edition of the Chinese Pharmacopoeia is synchronized with that of the international community. Starting in 2008, China will annually revise about 2000 national drug standards.
Reading: The establishment of a pharmaceutical standards system creates a solid barrier for public drug safety. Looking to the future, China's pharmaceutical standards system has entered a stage of comprehensive standardization and improvement. Under the principle of “improving the quality of pharmaceuticals and safeguarding public healthâ€, the level of pharmaceutical quality control will be fully enhanced.
(Source: "China's Drug Safety Regulatory Status" white paper, National Food and Drug Administration, China Chemical Pharmaceutical Industry Association, China Pharmaceutical Business Association)
sizes and adjustable structures to provide you with a good experience.
Camping lighting is essential because even the most impressive and handsome camping equipment still needs
a light to show its charm.
Even if the equipment is not so special, it still needs light to know where the meat is on the plate. So what are
you waiting for, hurry to pick up a camping light from our website?
From 1978 to 2008, only by using the words “overwhelming†could we describe changes in the Chinese pharmaceutical industry that have undergone the 30-year reform tide, and figures should be the best footnotes for these changes. Perhaps the numbers are concise, but concise but contain the rich content of 30 years of development and innovation; perhaps, the figures are trivial, but the trivial numbers can fully demonstrate the 30-year leap forward; perhaps, the figures are peaceful, However, Pinghe is echoing the magnificent symphony of the past 30 years.